Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study

BACKGROUND: Indacaterol is a long-acting beta-2 agonist for once-daily treatment of COPD. We evaluated the effects of indacaterol 150 μg on lung hyperinflation compared with placebo and open-label tiotropium 18 μg. We measured physical activity during treatment with indacaterol 150 μg and matched pl...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Watz, Henrik, Krippner, Felix, Kirsten, Anne, Magnussen, Helgo, Vogelmeier, Claus
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2014
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4197315/
https://ncbi.nlm.nih.gov/pubmed/25280934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-14-158
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk